Literature DB >> 15779849

Acute Chagas' disease: immunohistochemical characteristics of T cell infiltrate and its relationship with T. cruzi parasitic antigens.

Carmen Fuenmayor1, Maria L Higuchi, Hugo Carrasco, Henry Parada, Paulo Gutierrez, Vera Aiello, Sueli Palomino.   

Abstract

OBJECTIVE: The present work analysed endomyocardial biopsies of patients with acute Chagas' disease in order to evaluate the frequency and intensity of T. cruzi antigens, CD4+ and CD8+ T cells to determine the characteristics of this recurrent disease in Venezuela.
MATERIAL AND METHODS: Twelve endomyocardial biopsies of patients with Chagas' disease, 12 to 51 years old, (7M and 5F) were analysed. T. cruzi antigens and CD4+ (helper) and CD8+ (cytotoxic-suppressor) T cells were detected by the immunoperoxidase technique. The presence and intensity of lymphocytic myocarditis was evaluated according to the degree of myocardial fibre injury caused by inflammatory infiltrate.
RESULTS: Myocarditis was present in 100% of the cases. The mean numbers of CD4+ T cell and CD8+ T cell were 11.00 (+/- 10.29); 14.69 (+/- 13.08) and the CD4/CD8 T cell ratio was 0.75. T. cruzi antigens were detected in 58%. There was a good correlation between the numbers of CD4 and CD8 T cells of each case and a lack of correlation with the amount of T. cruzi antigens.
CONCLUSION: All patients with acute Chagas' disease show some degree of myocarditis that seems to be directly related to the presence of parasitic antigens. Both CD4 and CD8 T cells participate in this process. We are following these patients to see if patients with severe myocarditis and more parasite antigens in the acute phase will develop chronic heart failure.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15779849     DOI: 10.2143/AC.60.1.2005046

Source DB:  PubMed          Journal:  Acta Cardiol        ISSN: 0001-5385            Impact factor:   1.718


  12 in total

1.  Are increased frequency of macrophage-like and natural killer (NK) cells, together with high levels of NKT and CD4+CD25high T cells balancing activated CD8+ T cells, the key to control Chagas' disease morbidity?

Authors:  D M Vitelli-Avelar; R Sathler-Avelar; R L Massara; J D Borges; P S Lage; M Lana; A Teixeira-Carvalho; J C P Dias; S M Elói-Santos; O A Martins-Filho
Journal:  Clin Exp Immunol       Date:  2006-07       Impact factor: 4.330

Review 2.  Current concepts in immunoregulation and pathology of human Chagas disease.

Authors:  Walderez O Dutra; Kenneth J Gollob
Journal:  Curr Opin Infect Dis       Date:  2008-06       Impact factor: 4.915

3.  Cellular and genetic mechanisms involved in the generation of protective and pathogenic immune responses in human Chagas disease.

Authors:  Walderez Ornelas Dutra; Cristiane Alves Silva Menezes; Fernanda Nobre Amaral Villani; Germano Carneiro da Costa; Alexandre Barcelos Morais da Silveira; Débora d'Avila Reis; Kenneth J Gollob
Journal:  Mem Inst Oswaldo Cruz       Date:  2009-07       Impact factor: 2.743

Review 4.  Current understanding of immunity to Trypanosoma cruzi infection and pathogenesis of Chagas disease.

Authors:  Fabiana S Machado; Walderez O Dutra; Lisia Esper; Kenneth J Gollob; Mauro M Teixeira; Stephen M Factor; Louis M Weiss; Fnu Nagajyothi; Herbert B Tanowitz; Nisha J Garg
Journal:  Semin Immunopathol       Date:  2012-10-18       Impact factor: 9.623

5.  Chronic human infection with Trypanosoma cruzi drives CD4+ T cells to immune senescence.

Authors:  María Cecilia Albareda; Gabriela Carina Olivera; Susana A Laucella; María Gabriela Alvarez; Esteban Rodrigo Fernandez; Bruno Lococo; Rodolfo Viotti; Rick L Tarleton; Miriam Postan
Journal:  J Immunol       Date:  2009-08-19       Impact factor: 5.422

6.  Electrocardiographic findings in acutely and chronically T. cruzi-infected mice treated by a phenyl-substituted analogue of furamidine DB569.

Authors:  Elen M de Souza; Gabriel M Oliveira; Maria de Nazaré C Soeiro
Journal:  Drug Target Insights       Date:  2007-03-05

7.  Differential Activation of Human Monocytes and Lymphocytes by Distinct Strains of Trypanosoma cruzi.

Authors:  Luísa M D Magalhães; Agostinho Viana; Egler Chiari; Lúcia M C Galvão; Kenneth J Gollob; Walderez O Dutra
Journal:  PLoS Negl Trop Dis       Date:  2015-07-06

8.  Benznidazole affects expression of Th1, Th17 and Treg cytokines during acute experimental Trypanosoma cruzi infection.

Authors:  Mariana Gatto; Larissa Ragozo Cardoso Oliveira; Fernanda De Nuzzi Dias; João Pessoa Araújo Júnior; Carlos Roberto Gonçalves Lima; Eliana Peresi Lordelo; Rodrigo Mattos Dos Santos; Cilmery Suemi Kurokawa
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2017-12-12

9.  Therapeutic effects of sphingosine kinase inhibitor N,N-dimethylsphingosine (DMS) in experimental chronic Chagas disease cardiomyopathy.

Authors:  Juliana Fraga Vasconcelos; Cássio Santana Meira; Daniela Nascimento Silva; Carolina Kymie Vasques Nonaka; Pâmela Santana Daltro; Simone Garcia Macambira; Pablo Daniel Domizi; Valéria Matos Borges; Ricardo Ribeiro-Dos-Santos; Bruno Solano de Freitas Souza; Milena Botelho Pereira Soares
Journal:  Sci Rep       Date:  2017-07-21       Impact factor: 4.379

Review 10.  Chagas' disease: an update on immune mechanisms and therapeutic strategies.

Authors:  Silvia Beatriz Boscardin; Ana Claudia Troccoli Torrecilhas; Romina Manarin; Silvia Revelli; Elena Gonzalez Rey; Renata Rosito Tonelli; Ariel Mariano Silber
Journal:  J Cell Mol Med       Date:  2010-01-11       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.